FBTDX
Price
$158.20
Change
-$0.68 (-0.43%)
Updated
Nov 19 closing price
Net Assets
1B
JFNIX
Price
$81.94
Change
-$0.17 (-0.21%)
Updated
Nov 19 closing price
Net Assets
4.95B
Interact to see
Advertisement

FBTDX vs JFNIX

Header iconFBTDX vs JFNIX Comparison
Open Charts FBTDX vs JFNIXBanner chart's image
Franklin Biotechnology Discovery C
Price$158.20
Change-$0.68 (-0.43%)
VolumeN/A
Net Assets1B
Janus Henderson Global Life Sciences I
Price$81.94
Change-$0.17 (-0.21%)
VolumeN/A
Net Assets4.95B
FBTDX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
FBTDX vs. JFNIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTDX is a Hold and JFNIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.95B vs. FBTDX (1B). JFNIX pays higher dividends than FBTDX: JFNIX (0.35) vs FBTDX (0.00). FBTDX was incepted earlier than JFNIX: FBTDX (12 years) vs JFNIX (16 years). FBTDX (1.78) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. FBTDX (21.87). FBTDX has a lower initial minimum investment than JFNIX: FBTDX (1000) vs JFNIX (2500). FBTDX annual gain was more profitable for investors over the last year : 28.47 vs. JFNIX (10.62). JFNIX return over 5 years is better than : 17.36 vs. FBTDX (-7.83).
FBTDXJFNIXFBTDX / JFNIX
Total Expense Ratio1.770.77230%
Annual Report Gross Expense Ratio1.780.77231%
Fund Existence12 years16 years-
Gain YTD46.21820.465226%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1B4.95B20%
Annual Yield % from dividends0.000.35-
Returns for 1 year28.4710.62268%
Returns for 3 years60.4826.80226%
Returns for 5 years-7.8317.36-45%
Returns for 10 years-7.1052.25-14%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSCI559.592.76
+0.50%
MSCI
EVOK10.700.01
+0.09%
Evoke Pharma, Inc.
CMPX4.91-0.03
-0.51%
Compass Therapeutics
AGO88.03-0.59
-0.67%
Assured Guaranty Ltd
CEP13.54-0.85
-5.91%
Cantor Equity Partners Inc